Aspen Pharmacare Holdings Ltd (APN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aspen Pharmacare Holdings Ltd (APN) has a cash flow conversion efficiency ratio of 0.040x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ZAC3.35 Billion ≈ $1.78 Million USD) by net assets (ZAC84.89 Billion ≈ $45.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Aspen Pharmacare Holdings Ltd to measure how much of total assets are equity-financed.
Aspen Pharmacare Holdings Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Aspen Pharmacare Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Aspen Pharmacare Holdings Ltd (APN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Aspen Pharmacare Holdings Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aspen Pharmacare Holdings Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ambarella Inc
NASDAQ:AMBA
|
0.032x |
|
Offshore Oil Engineering Co Ltd
SHG:600583
|
0.038x |
|
Power Integrations Inc
NASDAQ:POWI
|
0.030x |
|
PTT OIL+RET.BUS.-NVDR- 10
F:7F80
|
0.019x |
|
Scorpio Tankers Inc.
F:S0QA
|
0.048x |
|
Hualan Biological EngineeringInc
SHE:002007
|
0.024x |
|
EQB Inc.
TO:EQB
|
-0.163x |
|
Quálitas Controladora S.A.B. de C.V.
MX:Q
|
0.103x |
Annual Cash Flow Conversion Efficiency for Aspen Pharmacare Holdings Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Aspen Pharmacare Holdings Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see APN stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | ZAC84.89 Billion ≈ $45.12 Million |
ZAC5.16 Billion ≈ $2.74 Million |
0.061x | -17.16% |
| 2024-06-30 | ZAC84.86 Billion ≈ $45.10 Million |
ZAC6.22 Billion ≈ $3.31 Million |
0.073x | +14.60% |
| 2023-06-30 | ZAC86.24 Billion ≈ $45.83 Million |
ZAC5.52 Billion ≈ $2.93 Million |
0.064x | -15.50% |
| 2022-06-30 | ZAC70.94 Billion ≈ $37.70 Million |
ZAC5.37 Billion ≈ $2.86 Million |
0.076x | -27.16% |
| 2021-06-30 | ZAC65.63 Billion ≈ $34.88 Million |
ZAC6.83 Billion ≈ $3.63 Million |
0.104x | -12.85% |
| 2020-06-30 | ZAC69.22 Billion ≈ $36.79 Million |
ZAC8.26 Billion ≈ $4.39 Million |
0.119x | +7.79% |
| 2019-06-30 | ZAC54.21 Billion ≈ $28.81 Million |
ZAC6.00 Billion ≈ $3.19 Million |
0.111x | -20.96% |
| 2018-06-30 | ZAC50.09 Billion ≈ $26.62 Million |
ZAC7.02 Billion ≈ $3.73 Million |
0.140x | -7.12% |
| 2017-06-30 | ZAC43.10 Billion ≈ $22.91 Million |
ZAC6.50 Billion ≈ $3.45 Million |
0.151x | +100.30% |
| 2016-06-30 | ZAC42.50 Billion ≈ $22.59 Million |
ZAC3.20 Billion ≈ $1.70 Million |
0.075x | -46.84% |
| 2015-06-30 | ZAC34.16 Billion ≈ $18.16 Million |
ZAC4.84 Billion ≈ $2.57 Million |
0.142x | +6.62% |
| 2014-06-30 | ZAC28.88 Billion ≈ $15.35 Million |
ZAC3.84 Billion ≈ $2.04 Million |
0.133x | -24.01% |
| 2013-06-30 | ZAC22.80 Billion ≈ $12.12 Million |
ZAC3.99 Billion ≈ $2.12 Million |
0.175x | +4.59% |
| 2012-06-30 | ZAC17.40 Billion ≈ $9.25 Million |
ZAC2.91 Billion ≈ $1.55 Million |
0.167x | -9.19% |
| 2011-06-30 | ZAC13.29 Billion ≈ $7.06 Million |
ZAC2.45 Billion ≈ $1.30 Million |
0.184x | -1.43% |
| 2010-06-30 | ZAC10.89 Billion ≈ $5.79 Million |
ZAC2.03 Billion ≈ $1.08 Million |
0.187x | -38.39% |
| 2009-06-30 | ZAC4.26 Billion ≈ $2.27 Million |
ZAC1.29 Billion ≈ $686.68K |
0.303x | +54.19% |
| 2008-06-30 | ZAC3.32 Billion ≈ $1.76 Million |
ZAC652.38 Million ≈ $346.71K |
0.197x | -33.71% |
| 2007-06-30 | ZAC2.39 Billion ≈ $1.27 Million |
ZAC708.56 Million ≈ $376.56K |
0.297x | +27.24% |
| 2006-06-30 | ZAC1.73 Billion ≈ $917.16K |
ZAC402.21 Million ≈ $213.76K |
0.233x | -59.58% |
| 2005-06-30 | ZAC1.11 Billion ≈ $588.19K |
ZAC638.20 Million ≈ $339.17K |
0.577x | +23.31% |
| 2004-06-30 | ZAC1.07 Billion ≈ $566.78K |
ZAC498.74 Million ≈ $265.05K |
0.468x | -3.67% |
| 2003-06-30 | ZAC794.98 Million ≈ $422.49K |
ZAC385.95 Million ≈ $205.11K |
0.485x | -- |
About Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more